Anthony DiMeo

Contacto de Relaciones con Inversores en AMNEAL PHARMACEUTICALS, INC. .

Health Technology

Consumer Services

Perfil

Anthony DiMeo is currently working as the Head of Investor Relations at Amneal Intermediate, Inc. and Amneal Pharmaceuticals, Inc. He completed his undergraduate degree from The University at Buffalo School of Management.

Cargos activos de Anthony DiMeo

Empresas	Cargo	Inicio
AMNEAL PHARMACEUTICALS, INC.	Contacto de Relaciones con Inversores	01/04/2021
Amneal Intermediate, Inc. Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ.	Contacto de Relaciones con Inversores	01/04/2021

Todos los cargos activos de Anthony DiMeo

Formación de Anthony DiMeo.

The University At Buffalo School of Management

Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Anthony DiMeo.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
AMNEAL PHARMACEUTICALS, INC.	Health Technology

Empresas privadas	1
Amneal Intermediate, Inc. Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ.	Health Technology